StockTipsArenaBeta

BUY Metropolis Healthcare Limited — Kush Bohra

BUYMetropolis Healthcare Limited

byKush BohraHorizon: NA (inferred Swing (≤2wk))29 Jul 2026via NDTV Profit

Entry₹585.5Inferred
Target₹621
Total upside +6.06% (call closed)
Stop loss₹567-3.16% risk
Exit₹5676 Aug 2026, 3:10 pm
Stop-loss hit-3.16%
Follow Kush Bohra for new calls(38% target hit, 114 closed calls)Get alertsWatch METROPOLIS for new buy/sell callsGet alertsSee 182 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 8:58 pm IST
3 supporting1 neutral0 opposing
Supports the BUY call (3)

Metropolis Healthcare Q1 profit rises 26% as TruHealth, Tier III markets gain momentum

NewsCnbc-Tv18·4 Aug · yesterday

(opens in new tab)

Metropolis Healthcare reported strong Q1FY27 performance with revenue up 17% to ₹450 crore and EBITDA up 27% YoY.

NSE · Press Release·4 Aug · yesterday

(opens in new tab)

Metropolis Healthcare reported strong Q1FY27 results with a 17% YoY increase in revenue to ₹450 crore and a 27% YoY increase in EBITDA to ₹113 crore. The company highlighted growth in patient and test

BSE · Company Update·4 Aug · yesterday

(opens in new tab)
Neutral / worth noting (1)

Metropolis Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.

NSE · Outcome of Board Meeting·4 Aug · yesterday

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.